tiprankstipranks
Trending News
More News >
Lisata Therapeutics (LSTA)
NASDAQ:LSTA
US Market

Lisata Therapeutics (LSTA) Income Statement

Compare
1,051 Followers

Lisata Therapeutics Income Statement

Last quarter (Q4 2025), Lisata Therapeutics's total revenue was $100.00K, a decrease of -90.00% from the same quarter last year. In Q4, Lisata Therapeutics's net income was $-2.95M. See Lisata Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 170.00K$ 1.00M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 24.00K$ 1.00M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 18.23M$ 23.41M$ 25.71M$ 57.60M$ 29.05M
Depreciation and Amortization
$ 146.00K$ 174.00K$ 189.00K$ 69.00K$ 55.00K
EBITDA
$ -18.06M$ -22.23M$ -25.52M$ -57.53M$ -29.00M
Operating Income
$ -18.21M$ -22.41M$ -25.71M$ -57.60M$ -29.05M
Other Income/Expenses
$ 661.00K$ 1.63M$ 2.54M$ 897.00K$ 76.00K
Pretax Income
$ -17.55M$ -20.78M$ -23.17M$ -56.70M$ -28.97M
Net Income
$ -16.59M$ -19.98M$ -20.84M$ -54.23M$ -27.47M
Per Share Metrics
Basic EPS
$ -1.91$ -2.40$ -2.58$ -10.47$ -7.45
Diluted EPS
$ -1.91$ -2.40$ -2.58$ -10.47$ -7.45
Weighted Average Shares Outstanding
8.69M 8.33M 8.07M 5.18M 3.69M
Weighted Average Shares Outstanding (Diluted)
8.69M 8.33M 8.07M 5.18M 3.69M
Currency in USD

Lisata Therapeutics Earnings and Revenue History